Teleflex Inc
TFX122.240USD
-0.050-0.04%
Cierre 12/24, 16:00（ET）Cotizaciones retrasadas 15 min
5.40BCap. mercado
PérdidaP/E TTM
Más Datos de Teleflex Inc Compañía
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Información de Teleflex Inc
Símbolo de cotizaciónTFX
Nombre de la empresaTeleflex Inc
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoKelly (Liam J)
Número de empleados14100
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 17
Dirección550 E Swedesford Rd
CiudadWAYNE
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal19087
Teléfono16102256800
Sitio Webhttps://www.teleflex.com/usa/en/#
Símbolo de cotizaciónTFX
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoKelly (Liam J)
Ejecutivos de Teleflex Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
50.99K
+3.03%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
10.22K
+10.84%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
6.54K
+18.04%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.66K
+9.70%
Mr. John C. Heinmiller
Mr. John C. Heinmiller
Independent Director
Independent Director
4.39K
+31.47%
Dr. Jaewon Ryu, M.D., J.D.
Dr. Jaewon Ryu, M.D., J.D.
Independent Director
Independent Director
3.08K
+95.06%
Ms. Neena M. Patil, J.D.
Ms. Neena M. Patil, J.D.
Independent Director
Independent Director
1.98K
+113.50%
Mr. John R. Deren
Mr. John R. Deren
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
50.99K
+3.03%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
10.22K
+10.84%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
6.54K
+18.04%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.66K
+9.70%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Vascular access
185.53M
23.76%
Interventional
170.02M
21.77%
Surgical
114.04M
14.60%
Anesthesia
96.39M
12.34%
OEM
78.67M
10.08%
Otro
136.24M
17.45%
Por regiónUSD
Nombre
Ganancia
Proporción
Americas
525.64M
67.31%
EMEA
166.23M
21.29%
Asia Pacific
89.03M
11.40%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Vascular access
185.53M
23.76%
Interventional
170.02M
21.77%
Surgical
114.04M
14.60%
Anesthesia
96.39M
12.34%
OEM
78.67M
10.08%
Otro
136.24M
17.45%
Estadísticas de accionistas
Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.05%
The Vanguard Group, Inc.
10.81%
T. Rowe Price Investment Management, Inc.
10.34%
Janus Henderson Investors
9.42%
AQR Capital Management, LLC
5.35%
Otro
53.03%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.05%
The Vanguard Group, Inc.
10.81%
T. Rowe Price Investment Management, Inc.
10.34%
Janus Henderson Investors
9.42%
AQR Capital Management, LLC
5.35%
Otro
53.03%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
57.71%
Investment Advisor/Hedge Fund
36.75%
Hedge Fund
9.11%
Pension Fund
1.76%
Sovereign Wealth Fund
1.36%
Research Firm
0.92%
Bank and Trust
0.57%
Family Office
0.37%
Individual Investor
0.34%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
1153
47.10M
106.58%
-5.30M
2025Q2
1158
48.67M
110.13%
-386.02K
2025Q1
1189
48.85M
110.52%
-721.30K
2024Q4
1180
47.47M
102.37%
-260.40K
2024Q3
1150
46.34M
98.36%
-1.83M
2024Q2
1147
46.98M
99.75%
-268.09K
2024Q1
1153
46.02M
97.70%
-1.89M
2023Q4
1170
46.05M
97.91%
-2.57M
2023Q3
1173
45.95M
97.77%
-3.19M
2023Q2
1201
46.87M
99.79%
-2.79M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
4.97M
11.25%
-385.28K
-7.19%
Jun 30, 2025
The Vanguard Group, Inc.
4.80M
10.86%
-269.49K
-5.32%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
5.94M
13.45%
-272.00K
-4.38%
Jun 30, 2025
Janus Henderson Investors
4.15M
9.39%
-176.31K
-4.08%
Jun 30, 2025
AQR Capital Management, LLC
409.32K
0.93%
+116.80K
+39.93%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
2.40M
5.44%
-373.80K
-13.46%
Jun 30, 2025
State Street Investment Management (US)
1.46M
3.3%
-69.05K
-4.52%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.24M
2.81%
+373.94K
+43.09%
Jun 30, 2025
Cooke & Bieler, L.P.
1.21M
2.73%
+148.44K
+14.04%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Invesco S&P SmallCap Health Care ETF
3.37%
First Trust Indxx Medical Devices ETF
2.09%
First Trust Health Care Alphadex Fund
1.77%
State Street SPDR S&P Health Care Equipment ETF
1.7%
Zacks Small/Mid Cap ETF
0.85%
State Street SPDR S&P 600 Small Cap Value ETF
0.75%
iShares S&P Small-Cap 600 Value ETF
0.75%
Distillate Small/Mid Cash Flow ETF
0.7%
VictoryShares Small Cap Free Cash Flow ETF
0.68%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.67%
Ver más
Invesco S&P SmallCap Health Care ETF
Proporción3.37%
First Trust Indxx Medical Devices ETF
Proporción2.09%
First Trust Health Care Alphadex Fund
Proporción1.77%
State Street SPDR S&P Health Care Equipment ETF
Proporción1.7%
Zacks Small/Mid Cap ETF
Proporción0.85%
State Street SPDR S&P 600 Small Cap Value ETF
Proporción0.75%
iShares S&P Small-Cap 600 Value ETF
Proporción0.75%
Distillate Small/Mid Cash Flow ETF
Proporción0.7%
VictoryShares Small Cap Free Cash Flow ETF
Proporción0.68%
iShares MSCI USA Small-Cap Min Vol Factor ETF
Proporción0.67%
Dividendos
Un total de
318.10M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Nov 06, 2025
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2025 going ex on Nov 14, 2025
Nov 14, 2025
Dec 15, 2025
Nov 14, 2025
Jul 31, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2025 going ex on Aug 15, 2025
Aug 15, 2025
Sep 15, 2025
Aug 15, 2025
May 12, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 16, 2025 going ex on May 20, 2025
May 20, 2025
Jun 16, 2025
May 20, 2025
Feb 27, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 17, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 17, 2025
Mar 07, 2025
Oct 31, 2024
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 16, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Dec 16, 2024
Nov 15, 2024
Aug 01, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 16, 2024 going ex on Aug 15, 2024
Aug 15, 2024
Sep 16, 2024
Aug 15, 2024
May 06, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 14, 2024 going ex on May 14, 2024
May 15, 2024
Jun 14, 2024
May 14, 2024
Feb 22, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 02, 2023
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2023 going ex on Nov 14, 2023
Nov 15, 2023
Dec 15, 2023
Nov 14, 2023
Aug 03, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2023 going ex on Aug 14, 2023
Aug 15, 2023
Sep 15, 2023
Aug 14, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Teleflex Inc?
Los cinco principales accionistas de Teleflex Inc son:
BlackRock Institutional Trust Company, N.A. posee 4.97M acciones, lo que representa el 11.25% del total de acciones.
The Vanguard Group, Inc. posee 4.80M acciones, lo que representa el 10.86% del total de acciones.
T. Rowe Price Investment Management, Inc. posee 5.94M acciones, lo que representa el 13.45% del total de acciones.
Janus Henderson Investors posee 4.15M acciones, lo que representa el 9.39% del total de acciones.
AQR Capital Management, LLC posee 409.32K acciones, lo que representa el 0.93% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 4.97M acciones, lo que representa el 11.25% del total de acciones.
The Vanguard Group, Inc. posee 4.80M acciones, lo que representa el 10.86% del total de acciones.
T. Rowe Price Investment Management, Inc. posee 5.94M acciones, lo que representa el 13.45% del total de acciones.
Janus Henderson Investors posee 4.15M acciones, lo que representa el 9.39% del total de acciones.
AQR Capital Management, LLC posee 409.32K acciones, lo que representa el 0.93% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Teleflex Inc?
Los tres principales tipos de accionista de Teleflex Inc son:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Investment Management, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Investment Management, Inc.
¿Cuántas instituciones poseen acciones de Teleflex Inc (TFX)?
A fecha de 2025Q3, 1153 instituciones poseen acciones de Teleflex Inc, con un valor de mercado combinado de aproximadamente 47.10M, lo que representa el 106.58% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -3.56%.
¿Cuál es la mayor fuente de ganancias de Teleflex Inc?
El FY2025Q2, el segmento empresarial Vascular access generó la ganancia más alta para Teleflex Inc, ascendiendo a 185.53M y representando el 23.76% de la ganancia total.
